IMMUNE STATE IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AT LATE TERMS AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
Abstract. Autologous hematopoietic stem cell transplantation (auto-HSCT) is one of the most effective methods for treatment of patients with various forms of hemoblastoses, both in adults and children. However, high-dose chemotherapy protocols used in this procedure are characterized by pronounced m...
Guardado en:
Autores principales: | N. V. Minaeva, T. P. Zagoskina, E. P. Svedentsov, G. A. Zaitceva, N. V. Isaeva, N. А. Zorina |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6a53315e671e45e58d550dcbb5a59886 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CLINICAL EFFECTS OF MESENCHYMAL STROMAL CELLS IN LYMPHOMA PATIENTS WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: E. V. Batorov, et al.
Publicado: (2012) -
Hematopoietic stem cell transplantation: clinical use and perspectives
por: Barriga,Francisco, et al.
Publicado: (2012) -
High-dose chemotherapy following autologous hematopoietic stem cell transplantation for multiple myeloma in the real world setting. Single-center experience
por: Nikita E. Mochkin, et al.
Publicado: (2020) -
Trasplante alogénico de precursores hematopoyéticos en pacientes con síndrome de Wiskott-Aldrich
por: Wietstruck P,María Angélica, et al.
Publicado: (2007) -
Iron chelation therapy improves hematopoiesis in patients with hematological malignancy after hematopoietic stem cell transplantation
por: ZENG Cong, et al.
Publicado: (2021)